Literature DB >> 22517955

In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.

Habib Rahbar1, Savannah C Partridge, Wendy B Demartini, Robert L Gutierrez, Kimberly H Allison, Sue Peacock, Constance D Lehman.   

Abstract

PURPOSE: To develop a model incorporating dynamic contrast material-enhanced (DCE) and diffusion-weighted (DW) magnetic resonance (MR) imaging features to differentiate high-nuclear-grade (HNG) from non-HNG ductal carcinoma in situ (DCIS) in vivo.
MATERIALS AND METHODS: This HIPAA-compliant study was approved by the institutional review board and requirement for informed consent was waived. A total of 55 pure DCIS lesions (19 HNG, 36 non-HNG) in 52 women who underwent breast MR imaging at 1.5 T with both DCE and DW imaging (b = 0 and 600 sec/mm(2)) were retrospectively reviewed. The following lesion characteristics were recorded or measured: DCE morphology, DCE maximum lesion size, peak initial enhancement at 90 seconds, worst-curve delayed enhancement kinetics, apparent diffusion coefficient (ADC), contrast-to-noise ratio (CNR) at DW imaging with b values of 0 and 600 sec/mm(2), and T2 signal effects (measured with CNR at b = 0 sec/mm(2)). Univariate and stepwise multivariate logistic regression modeling was performed to identify MR imaging features that optimally discriminated HNG from non-HNG DCIS. Discriminative abilities of models were compared by using the area under the receiver operating characteristic curve (AUC).
RESULTS: HNG lesions exhibited larger mean maximum lesion size (P = .02) and lower mean CNR for images with b value of 600 sec/mm(2) (P = .004), allowing discrimination of HNG from non-HNG DCIS (AUC = 0.71 for maximum lesion size, AUC = 0.70 for CNR at b = 600 sec/mm(2)). Differences in CNR for images with b value of 0 sec/mm(2) (P = .025) without corresponding differences in ADC values were observed between HNG and non-HNG lesions. Peak initial enhancement was the only kinetic variable to approach significance (P = .05). No differences in lesion morphology (P = .11) or worst-curve delayed enhancement kinetics (P = .97) were observed. A multivariate model combining CNR for images with b value of 600 sec/mm(2) and maximum lesion size most significantly discriminated HNG from non-HNG (AUC = 0.81).
CONCLUSION: The preliminary findings suggest that DCE and DW MR imaging features may aid in identifying patients with high-risk DCIS. Further study may yield a model combining MR characteristics with histopathologic data to facilitate lesion-specific targeted therapies. © RSNA, 2012.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517955      PMCID: PMC3329273          DOI: 10.1148/radiol.12111368

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

1.  Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.

Authors:  Mami Iima; Denis Le Bihan; Ryosuke Okumura; Tomohisa Okada; Koji Fujimoto; Shotaro Kanao; Shiro Tanaka; Masakazu Fujimoto; Hiromi Sakashita; Kaori Togashi
Journal:  Radiology       Date:  2011-06-01       Impact factor: 11.105

Review 2.  Ductal carcinoma in-situ: an update for clinical practice.

Authors:  Neill Patani; Yazan Khaled; Sara Al Reefy; Kefah Mokbel
Journal:  Surg Oncol       Date:  2010-11-24       Impact factor: 3.279

3.  Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.

Authors:  Meagan E Brennan; Robin M Turner; Stefano Ciatto; M Luke Marinovich; James R French; Petra Macaskill; Nehmat Houssami
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

4.  Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI.

Authors:  Savannah C Partridge; Wendy B Demartini; Brenda F Kurland; Peter R Eby; Steven W White; Constance D Lehman
Journal:  J Magn Reson Imaging       Date:  2010-03       Impact factor: 4.813

5.  Characterization of ductal carcinoma in situ on diffusion weighted breast MRI.

Authors:  Habib Rahbar; Savannah C Partridge; Peter R Eby; Wendy B Demartini; Robert L Gutierrez; Sue Peacock; Constance D Lehman
Journal:  Eur Radiol       Date:  2011-05-12       Impact factor: 5.315

6.  Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics.

Authors:  S C Partridge; H Rahbar; R Murthy; X Chai; B F Kurland; W B DeMartini; C D Lehman
Journal:  Magn Reson Med       Date:  2011-01-19       Impact factor: 4.668

Review 7.  Magnetic resonance imaging in the evaluation of ductal carcinoma in situ.

Authors:  Constance D Lehman
Journal:  J Natl Cancer Inst Monogr       Date:  2010

8.  High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement.

Authors:  H Neubauer; Mengxia Li; R Kuehne-Heid; A Schneider; W A Kaiser
Journal:  Br J Radiol       Date:  2003-01       Impact factor: 3.039

Review 9.  Standard for breast conservation therapy in the management of invasive breast carcinoma.

Authors:  Monica Morrow; Eric A Strom; Lawrence W Bassett; D David Dershaw; Barbara Fowble; Armando Giuliano; Jay R Harris; Frances O'Malley; Stuart J Schnitt; S Eva Singletary; David P Winchester
Journal:  CA Cancer J Clin       Date:  2002 Sep-Oct       Impact factor: 508.702

10.  National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.

Authors:  Carmen J Allegra; Denise R Aberle; Pamela Ganschow; Stephen M Hahn; Clara N Lee; Sandra Millon-Underwood; Malcolm C Pike; Susan D Reed; Audrey F Saftlas; Susan A Scarvalone; Arnold M Schwartz; Carol Slomski; Greg Yothers; Robin Zon
Journal:  J Natl Cancer Inst       Date:  2010-01-13       Impact factor: 13.506

View more
  34 in total

1.  Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.

Authors:  Naoko Mori; Hideki Ota; Shunji Mugikura; Chiaki Takasawa; Junya Tominaga; Takanori Ishida; Mika Watanabe; Kei Takase; Shoki Takahashi
Journal:  Eur Radiol       Date:  2013-06-04       Impact factor: 5.315

2.  Quantitative breast MRI: 2D histogram analysis of diffusion tensor parameters in normal tissue.

Authors:  Julia Wiederer; Shila Pazahr; Cornelia Leo; Daniel Nanz; Andreas Boss
Journal:  MAGMA       Date:  2013-09-03       Impact factor: 2.310

3.  Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.

Authors:  Tianwen Xie; Qiufeng Zhao; Caixia Fu; Qianming Bai; Xiaoyan Zhou; Lihua Li; Robert Grimm; Li Liu; Yajia Gu; Weijun Peng
Journal:  Eur Radiol       Date:  2018-11-06       Impact factor: 5.315

4.  Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2- breast cancers.

Authors:  Nita Amornsiripanitch; Vicky T Nguyen; Habib Rahbar; Daniel S Hippe; Vijayakrishna K Gadi; Mara H Rendi; Savannah C Partridge
Journal:  J Magn Reson Imaging       Date:  2017-11-27       Impact factor: 4.813

5.  Feasibility analysis of early temporal kinetics as a surrogate marker for breast tumor type, grade, and aggressiveness.

Authors:  Laura Heacock; Alana A Lewin; Yiming Gao; James S Babb; Samantha L Heller; Amy N Melsaether; Neeti Bagadiya; Sungheon G Kim; Linda Moy
Journal:  J Magn Reson Imaging       Date:  2017-11-27       Impact factor: 4.813

Review 6.  How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?

Authors:  Habib Rahbar; Elizabeth S McDonald; Janie M Lee; Savannah C Partridge; Christoph I Lee
Journal:  Acad Radiol       Date:  2016-03-23       Impact factor: 3.173

7.  Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.

Authors:  Jin You Kim; Jin Joo Kim; Ji Won Lee; Nam Kyung Lee; Geewon Lee; Taewoo Kang; Heesung Park; Yo Han Son; Robert Grimm
Journal:  Eur Radiol       Date:  2018-08-02       Impact factor: 5.315

Review 8.  Diffusion-weighted breast MRI: Clinical applications and emerging techniques.

Authors:  Savannah C Partridge; Noam Nissan; Habib Rahbar; Averi E Kitsch; Eric E Sigmund
Journal:  J Magn Reson Imaging       Date:  2016-09-30       Impact factor: 4.813

9.  Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors.

Authors:  Gene Young Cho; Linda Moy; Sungheon G Kim; Steven H Baete; Melanie Moccaldi; James S Babb; Daniel K Sodickson; Eric E Sigmund
Journal:  Eur Radiol       Date:  2015-11-28       Impact factor: 5.315

Review 10.  Multiparametric MR Imaging of Breast Cancer.

Authors:  Habib Rahbar; Savannah C Partridge
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.